XML 41 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Corrections to Previously Issued Consolidated Financial Statements (Details Textual) - USD ($)
 2 Months Ended 12 Months Ended
Sep. 30, 2015
Sep. 30, 2017
Sep. 30, 2016
Jul. 20, 2015
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Due to related party   $ 4,113,000 $ 6,500,000  
Total liabilities   4,147,914 6,556,470  
Total liabilities increased   6,500,000    
Additional paid in capital   13,788,574 4,733,461  
Additional paid in capital increased   60    
Accumulated deficit   (15,395,384) (11,323,401)  
Accumulated deficit increased   6,500,000    
Total equity (deficit) $ 633,357 (1,393,063) (6,379,118) $ 897,001
Total equity (deficit) decreased   6,500,000    
Selling, general and administrative expenses   707,142 599,303  
Selling, general and administrative expenses decreased   3,500,000    
Research and development expenses   3,151,162 10,000,000  
Research and development expenses increased   10,000,000    
Net loss from operations   (3,996,342) (10,997,295)  
Loss from continuing operations before taxes   (4,071,153) (11,006,963)  
Loss from continuing operations before taxes increased   6,500,000    
Net loss for the period (315,602) $ (4,071,983) $ (11,007,799)  
Basic and diluted loss per share   $ (0.02) $ (0.06)  
Basic and diluted loss per share increased   $ 0.06    
Net loss from continuing operations $ (315,602) $ (4,071,983) $ (11,007,799)  
Net loss from continuing operations increased   6,500,000    
Issuance of common stock for compensation and recapitalization   1,295,324  
(Decrease) increase in due to related party   2,353,000 6,477,483  
(Decrease) increase in due to related party increased   $ 6,500,000    
Scenario, Previously Reported [Member]        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Due to related party      
Total liabilities     56,470  
Additional paid in capital     4,733,401  
Accumulated deficit     (4,823,401)  
Total equity (deficit)     120,882  
Selling, general and administrative expenses     4,497,263  
Research and development expenses      
Net loss from operations     (4,497,295)  
Loss from continuing operations before taxes     (4,506,963)  
Net loss for the period     $ (4,507,799)  
Basic and diluted loss per share     $ 0.00  
Net loss from continuing operations     $ (4,507,799)  
Issuance of common stock for compensation and recapitalization     1,295,324  
(Decrease) increase in due to related party     (22,517)  
Restatement Adjustment [Member]        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Due to related party     6,500,000  
Total liabilities     6,556,470  
Additional paid in capital     4,733,461  
Accumulated deficit     (11,323,401)  
Total equity (deficit)     (6,379,118)  
Selling, general and administrative expenses     997,263  
Research and development expenses     10,000,000  
Net loss from operations     (10,997,295)  
Loss from continuing operations before taxes     (11,006,963)  
Net loss for the period     $ (11,007,799)  
Basic and diluted loss per share     $ (0.06)  
Net loss from continuing operations     $ (11,007,799)  
Issuance of common stock for compensation and recapitalization     1,295,324  
(Decrease) increase in due to related party     6,477,483  
Adjustments One [Member]        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Due to related party      
Total liabilities      
Additional paid in capital     60  
Accumulated deficit      
Total equity (deficit)      
Selling, general and administrative expenses     60  
Research and development expenses      
Net loss from operations     (60)  
Loss from continuing operations before taxes     (60)  
Net loss for the period     $ (60)  
Basic and diluted loss per share     $ 0.00  
Net loss from continuing operations     $ (60)  
Issuance of common stock for compensation and recapitalization     60  
(Decrease) increase in due to related party      
Adjustments [Member]        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Due to related party     6,500,000  
Total liabilities     6,500,000  
Additional paid in capital      
Accumulated deficit     (6,500,000)  
Total equity (deficit)     (6,500,000)  
Selling, general and administrative expenses     (3,500,060)  
Research and development expenses     10,000,000  
Net loss from operations     (6,499,940)  
Loss from continuing operations before taxes     (6,499,940)  
Net loss for the period     $ (6,499,940)  
Basic and diluted loss per share     $ (0.06)  
Net loss from continuing operations     $ (6,499,940)  
Issuance of common stock for compensation and recapitalization     (60)  
(Decrease) increase in due to related party     $ 6,500,000